Terpenoid ID | TKC020479 |
![]() |
Cell line | 0 | |
Protein target | 11 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 8 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC020479 | RAW264.7 | RAW264 | 37.0 | % | Survival | C21604 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC020479 | Q4QYD9 | Heat sensitive channel TRPV3 | 29000 | nM | EC50 | |
TKC020479 | O42275 | Acetylcholinesterase | ache | 458230 | nM | IC50 |
TKC020479 | P0DTD1 | Replicase polyprotein 1ab | rep | 17 | % | Inhibition |
TKC020479 | P35354 | Prostaglandin G/H synthase 2 | PTGS2 | <30 | % | Inhibition |
TKC020479 | P81908 | Cholinesterase | BCHE | 226130 | nM | IC50 |
TKC020479 | P08659 | Luciferin 4-monooxygenase | 40533 | nM | Potency | |
TKC020479 | Q8NHB7 | Olfactory receptor 5K1 | OR5K1 | >75 | % | Inhibition |
TKC020479 | P02545 | Prelamin-A/C | LMNA | 794 | nM | Potency |
TKC020479 | O75762 | Transient receptor potential cation channel subfamily A member 1 | TRPA1 | 6000 | nM | EC50 |
TKC020479 | O75762 | Transient receptor potential cation channel subfamily A member 1 | TRPA1 | 6000 | nM | EC50 |
TKC020479 | O75762 | Transient receptor potential cation channel subfamily A member 1 | TRPA1 | 60256 | nM | EC50 |
TKC020479 | O42713 | Polyphenol oxidase 2 | PPO2 | 500000 | nM | IC50 |
TKC020479 | P0DTE4 | UDP-glucuronosyltransferase 2A1 | UGT2A1 | 0 | pm/min/mg | Activity |
TKC020479 | P22309 | UDP-glucuronosyltransferase 1A1 | UGT1A1 | 0 | pm/min/mg | Activity |
TKC020479 | P22310 | UDP-glucuronosyltransferase 1A4 | UGT1A4 | 15 | pm/min/mg | Activity |
TKC020479 | Q75NA5 | Gamma-aminobutyric acid receptor subunit beta | Rdl | 180 | % | Activity |
TKC020479 | Q6RI86 | Transient receptor potential cation channel subfamily A member 1 | Trpa1 | 125400 | nM | IC50 |
TKC020479 | Q8R455 | Transient receptor potential cation channel subfamily M member 8 | Trpm8 | 52200 | nM | EC50 |
TKC020479 | O60656 | UDP-glucuronosyltransferase 1A9 | UGT1A9 | 400 | pm/min/mg | Activity |
TKC020479 | P9WIB9 | Secreted chorismate mutase | Rv1885c | 28400 | nM | IC50 |
TKC020479 | P19224 | UDP-glucuronosyltransferase 1-6 | UGT1A6 | 0 | pm/min/mg | Activity |
TKC020479 | P35503 | UDP-glucuronosyltransferase 1A3 | UGT1A3 | 69 | pm/min/mg | Activity |
TKC020479 | P54855 | UDP-glucuronosyltransferase 2B15 | UGT2B15 | 0 | pm/min/mg | Activity |
TKC020479 | Q13936 | Voltage-dependent L-type calcium channel subunit alpha-1C | CACNA1C | 158000 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P35354 | PGH2_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P35354 | PGH2_HUMAN | Chronic pain [ICD-11: MG30] |
P35354 | PGH2_HUMAN | Endometriosis [ICD-11: GA10] |
P35354 | PGH2_HUMAN | Female pelvic pain [ICD-11: GA34] |
P35354 | PGH2_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 | PGH2_HUMAN | Indeterminate colitis [ICD-11: DD72] |
P35354 | PGH2_HUMAN | Knee osteoarthritis [ICD-11: FA01] |
P35354 | PGH2_HUMAN | Migraine [ICD-11: 8A80] |
P35354 | PGH2_HUMAN | Osteoarthritis [ICD-11: FA00-FA05] |
P35354 | PGH2_HUMAN | Pain [ICD-11: MG30-MG3Z] |
P35354 | PGH2_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P35354 | PGH2_HUMAN | Tuberculosis [ICD-11: 1B10-1B12] |
P35354 | PGH2_HUMAN | Shoulder lesion [ICD-11: FB53] |
P35354 | PGH2_HUMAN | Soft tissue disorder [ICD-11: FB56] |
P35354 | PGH2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 | PGH2_HUMAN | Asthma [ICD-11: CA23] |
P35354 | PGH2_HUMAN | Gout [ICD-11: FA25] |
P35354 | PGH2_HUMAN | General pain disorder [ICD-11: 8E43] |
P35354 | PGH2_HUMAN | Lupus erythematosus [ICD-11: 4A40] |
P35354 | PGH2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 | PGH2_HUMAN | Large intestine polyp [ICD-11: DB35] |
P35354 | PGH2_HUMAN | Lung cancer [ICD-11: 2C25] |
P35354 | PGH2_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P35354 | PGH2_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 | PGH2_HUMAN | Colorectal cancer [ICD-11: 2B91] |
P35354 | PGH2_HUMAN | Fever [ICD-11: MG26] |
P35354 | PGH2_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75762 | TRPA1_HUMAN | Upper respiratory tract disorder [ICD-11: CA0Z] |
O75762 | TRPA1_HUMAN | Neuropathy [ICD-11: 8C0Z] |
O75762 | TRPA1_HUMAN | Pain [ICD-11: MG30-MG3Z] |
O75762 | TRPA1_HUMAN | Upper respiratory tract disorder [ICD-11: CA0Z] |
O75762 | TRPA1_HUMAN | Neuropathy [ICD-11: 8C0Z] |
O75762 | TRPA1_HUMAN | Pain [ICD-11: MG30-MG3Z] |
O75762 | TRPA1_HUMAN | Upper respiratory tract disorder [ICD-11: CA0Z] |
O75762 | TRPA1_HUMAN | Neuropathy [ICD-11: 8C0Z] |
O75762 | TRPA1_HUMAN | Pain [ICD-11: MG30-MG3Z] |
P22309 | UD11_HUMAN | Inborn porphyrin/heme metabolism error [ICD-11: 5C58] |
Q13936 | CAC1C_HUMAN | Alzheimer disease [ICD-11: 8A20] |
Q13936 | CAC1C_HUMAN | Angina pectoris [ICD-11: BA40] |
Q13936 | CAC1C_HUMAN | Genetic cardiac arrhythmia [ICD-11: BC65] |
Q13936 | CAC1C_HUMAN | Unspecific body region injury [ICD-11: ND56] |
Q13936 | CAC1C_HUMAN | Heart failure [ICD-11: BD10-BD1Z] |